Skip to main content

Table 1 Laboratory data on admission

From: Hepatic angiomyolipoma: differential diagnosis from other liver tumors in a special reference to vascular imaging - importance of early drainage vein

WBC

2,200/mm3

ChE

338 IU/L

RBC

405 × 104/mm3

Na

142 mEq/L

Hb

12.7 g/dL

K

4.0 mEq/L

Ht

38.3%

Cl

103 mEq/L

Plt

16.6 × 104/mm3

Ca

9.6 mg/dL

AST

17 IU/L

CRP

0.02 mg/dL

ALT

14 IU/L

Glucose

88 mg/dL

ALP

223 IU/L

HbA1c

5.1%

LDH

144 IU/L

CEA

2.6 ng/mL

γ-GTP

30 IU/L

CA19-9

17.4 U/mL

T-Bil

0.8 mg/dL

AFP

3.3 ng/mL

TP

7.0 g/dL

AFP-L3

0.5%

Alb

4.5 g/dL

PIVKA-II

15 mAU/mL

BUN

13.5 mg/dL

HBS antigen

(−)

Cre

0.52 mg/dL

HCV antibody

(−)

AMY

332 IU/L

  
  1. WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Ht, hematocrit; Plt, platelet; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactic dehydrogenase; γ-GTP, gamma glutamyl transpeptidase; T. Bil, total bilirubin; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cr, creatinine; AMY, amylase; CHE, cholinesterase; Na, sodium; K, potassium; Cl, chloride; Ca, calcium; CRP, C-reactive protein; HbA1c, hemoglobin A1c; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; AFP, alpha-fetoprotein; AFP-L3, alpha-fetoprotein fraction L3; PIVKA-II, protein induced by vitamin K absence or antagonist-II; HBs antigen, hepatitis B surface antigen; HCV antibody, hepatitis C virus antibody.